High Throughput Drug Synergy Testing in a Clinical Trial of Panobinostat, Carfilzomib, Dexamethasone to Define Response Biomarkers for Relapsed/Refractory Multiple Myeloma

被引：2

作者：

Becker, Pamela S. ^{[1
,2
]}

Quach, Kim ^{[3
]}

Gooley, Ted A. ^{[1
]}

Libby, Edward N., III ^{[1
,4
]}

Cowan, Andrew J. ^{[5
]}

Coffey, David G. ^{[1
,4
]}

Degraaff, Bret Gary ^{[6
]}

Hammer, Cody ^{[3
]}

Dai, Jin

Chien, Sylvia ^{[7
]}

Epworth, Josh ^{[8
]}

Zecha, Gabrielle A. ^{[8
,9
]}

Smith, Heather ^{[8
]}

Martins, Timothy S. ^{[7
]}

机构：

[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA

[2] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA

[3] Univ Washington, Div Hematol, Seattle, WA 98195 USA

[4] Univ Washington, Dept Med, Seattle, WA USA

[5] Univ Washington, Div Med Oncol, Seattle, WA 98195 USA

[6] Univ Washington, Sch Med, Seattle, WA USA

[7] Univ Washington, Dept Med, Div Hematol, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA

[8] Seattle Cancer Care Alliance, Seattle, WA USA

[9] WA SCCA, Seattle, WA USA

来源：

关键词：

D O I：

10.1182/blood-2019-130990

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1902

引用

页数：3